Stay updated on Lomvastomig in Solid Tumors Dose Escalation Clinical Trial
Sign up to get notified when there's something new on the Lomvastomig in Solid Tumors Dose Escalation Clinical Trial page.

Latest updates to the Lomvastomig in Solid Tumors Dose Escalation Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedAdded revision v3.6.3 to the history and removed revision v3.6.2, indicating a small update to the page's release notes.SummaryDifference0.1%

- Check18 days agoChange DetectedFooter now shows Revision: v3.6.2 instead of v3.6.0, indicating a recent site update. This reflects a platform/UI version bump rather than any modification to trial data or history content.SummaryDifference0.1%

- Check32 days agoChange DetectedThe latest version updates the recruitment status to indicate no further participant enrollment and updates the record to Revision: v3.6.0, replacing the previous v3.5.5 entry.SummaryDifference0.2%

- Check40 days agoChange DetectedThe page revision label changed from v3.5.4 to v3.5.5. This indicates a new release of the page version without altering the study content or history data.SummaryDifference0.1%

- Check61 days agoChange DetectedRevision: v3.5.4 has been added and Revision: v3.5.3 has been removed. This updates the page's revision history to reflect the latest version rather than altering trial data or public content.SummaryDifference0.1%

- Check82 days agoChange DetectedThe page’s interface revision indicator has been updated from v3.5.2 to v3.5.3, reflecting a site/version update rather than any change to the underlying trial record.SummaryDifference0.1%

Stay in the know with updates to Lomvastomig in Solid Tumors Dose Escalation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lomvastomig in Solid Tumors Dose Escalation Clinical Trial page.